Golden, CO, United States of America

Biointellisense, Inc.


USPTO Granted Patents = 10


Trademarks = 8

Forward Citations = 44

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal David Jonq Wang (9 out of 17 patents)

silverMedal Mark A Ross (6 out of 53 patents)

bronzeMedal James R Mault (5 out of 38 patents)

4.  Henry Leung (4 out of 4 patents)

5.  Eduardo Chan (2 out of 5 patents)

6.  Sam Jones (2 out of 2 patents)

7.  Eleanor Nina Drake (2 out of 2 patents)

8.  Thomas Dietiker (1 out of 4 patents)

9.  Brian Chris Ro (1 out of 1 patent)

10.  Tracy G Cheng (1 out of 1 patent)


10 patents:

Company Overview
Biointellisense, Inc. is a technology company based in Golden, Colorado, specializing in advanced remote patient monitoring solutions. The organization develops innovative medical devices and software that enable continuous health monitoring, enhancing patient care and clinical outcomes. By leveraging cutting-edge sensor technology and data analytics, Biointellisense aims to transform healthcare delivery, making it more proactive and personalized. Their focus on real-time health insights supports both patients and healthcare providers in managing chronic conditions effectively.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Biointellisense, Inc. USPTO Patent Assignee Logo
10 Patents

#41 in Golden, CO

#639 in Colorado

#29,882 in US

#56,092 in the World

Golden, CO (US)
Golden, CO, United States of America
Forward Citations = 44

10 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biointellisense, Inc.. Retrieved from https://idiyas.com/company/biointellisense

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…